These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 2820312

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV.
    Cancer; 1996 Oct 15; 78(8):1701-7. PubMed ID: 8859183
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: a pilot study by the Lung Cancer Working Party (Belgium).
    Sculier JP, Klastersky J, Dumont JP, Vandermoten G, Rocmans P, Libert P, Ravez P, Becquart D, Mommen P, Dalesio O.
    Cancer Treat Rep; 1986 Jun 15; 70(6):773-5. PubMed ID: 3731139
    [Abstract] [Full Text] [Related]

  • 26. [Concurrent high-dose thoracic irradiation plus daily low-dose cisplatin and vindesine in locally advanced unresectable stage III non-small cell lung cancer].
    Nakano K, Kumagai K, Ishida H, Kohjima N, Hiramoto T, Hada Y.
    Gan To Kagaku Ryoho; 1996 Jan 15; 23(1):57-61. PubMed ID: 8546470
    [Abstract] [Full Text] [Related]

  • 27. Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
    Kris MG, Gralla RJ, Kalman LA, Kelsen DP, Casper ES, Burke MT, Groshen S, Cibas IR, Bagin R, Heelan RT.
    Cancer Treat Rep; 1985 Apr 15; 69(4):387-95. PubMed ID: 3888388
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [MEP therapy of advanced lung cancer].
    Komuro Y, Ohnishi M, Saitoh A, Morohashi Y.
    Gan To Kagaku Ryoho; 1987 Sep 15; 14(9):2688-91. PubMed ID: 2820313
    [Abstract] [Full Text] [Related]

  • 31. [Combination of cisplatin-mitomycin-vindesine for inoperable, non-small-cell bronchial cancers. French study group in pneumo-cancerology].
    Kleisbauer JP, Thomas P, Perol M, Taytard A, Poirier R, Collus MJ, Guerin JC, Vergnenegre A, Balmes P, Carles P.
    Rev Mal Respir; 1993 Sep 15; 10(4):307-12. PubMed ID: 7694331
    [Abstract] [Full Text] [Related]

  • 32. Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer.
    Recchia F, Sica G, De Filippis S, Rea S, Frati L.
    Anticancer Res; 1997 Sep 15; 17(5B):3761-5. PubMed ID: 9427776
    [Abstract] [Full Text] [Related]

  • 33. [Pilot combination phase II study of mitomycin C plus cisplatin for non-small cell lung cancer].
    Shimizu E, Kamei T, Kimura K, Mukai J, Nakamura Y, Kunishige E, Fukuta K, Tani K, Sone S, Ogura T.
    Gan To Kagaku Ryoho; 1989 Dec 15; 16(12):3719-23. PubMed ID: 2556971
    [Abstract] [Full Text] [Related]

  • 34. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
    Ohta M, Hara N, Ichikawa Y, Kanda T, Shima K, Tamura K, Hokama M.
    Gan To Kagaku Ryoho; 1988 Jun 15; 15(6):1901-8. PubMed ID: 2454615
    [Abstract] [Full Text] [Related]

  • 35. [A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].
    Furuse K, Fukuoka M, Asamoto H, Niitani H, Kimura I, Sakuma A, Yamaguchi Y.
    Gan To Kagaku Ryoho; 1992 Jul 15; 19(7):1019-26. PubMed ID: 1320846
    [Abstract] [Full Text] [Related]

  • 36. [A randomized trial with various combinations of cis-platinum (CDDP), mitomycin C (MMC), peplomycin (PEP) and ftorafur (FT) in the treatment of non-small cell lung cancer].
    Nakabayashi T, Yasuda S, Miyamoto H, Abe S, Ohosaki Y.
    Gan To Kagaku Ryoho; 1986 Oct 15; 13(10):2998-3004. PubMed ID: 2429619
    [Abstract] [Full Text] [Related]

  • 37. Cisplatin and vindesine for disseminated non-small cell lung cancer. Results of a prospective trial with 81 patients.
    Tourani JM, Penaud D, Caubarrere I, Darse J, Balzon JC, Boita F, Lebas FX, Lafitte JJ, Andrieu JM.
    Bull Cancer; 1990 Oct 15; 77(11):1107-13. PubMed ID: 2177357
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.
    Fukuoka M, Masuda N, Furuse K, Negoro S, Takada M, Matsui K, Takifuji N, Kudoh S, Kawahara M, Ogawara M.
    J Clin Oncol; 1991 Apr 15; 9(4):606-13. PubMed ID: 1648597
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.